The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease.
about
Effect of redox modulating NRF2 activators on chronic kidney diseaseDiscontinued in 2013: diabetic drugs.A pharmaco-metabonomic study on chronic kidney disease and therapeutic effect of ergone by UPLC-QTOF/HDMSRole of nuclear factor erythroid 2-related factor 2 in the oxidative stress-dependent hypertension associated with the depletion of DJ-1The effect of Nrf2 pathway activation on human pancreatic islet cells.Diabetic nephropathy: What does the future hold?An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure.Betulinic acid enhances TGF-β signaling by altering TGF-β receptors partitioning between lipid-raft/caveolae and non-caveolae membrane microdomains in mink lung epithelial cells.Bardoxolone Methyl Prevents High-Fat Diet-Induced Colon Inflammation in Mice.Therapies on the Horizon for Diabetic Kidney Disease.Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.CDDO and Its Role in Chronic Diseases.Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD.Salutary effect of pre-treatment with an Nrf2 inducer on ischemia reperfusion injury in the rat liver.Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption.Synthetic Triterpenoid RTA dh404 (CDDO-dhTFEA) Ameliorates Acute Pancreatitis.Pharmacological activation of Nrf2 pathway improves pancreatic islet isolation and transplantation.Bardoxolone-the Phoenix?Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study.Epigallocatechin-3-Gallate Attenuates Oxidative Stress and Inflammation in Obstructive Nephropathy via NF-κB and Nrf2/HO-1 Signalling Pathway Regulation.
P2860
Q26827726-B761D0D7-2059-47AB-85D0-7EAD7335712AQ34664870-D574B233-69FE-4590-B879-97D81EC6A3BBQ35533024-C33BFEE3-1728-4FB7-8C8C-DA2465A951D1Q35611392-2C82A2CD-4091-4F57-9C5C-8589DAB01AF3Q35674148-66B5EC30-6B96-4DDC-8955-B0E4C0278FE6Q36441616-47CF372F-3B16-47DF-BF13-87E5E122A218Q36606173-98403726-8734-4647-AC57-66FCBEC7A348Q36625618-E915C5CE-4B56-4406-B837-D6C6108232EDQ36756653-5B52765B-A2F3-442D-95F5-77AD4749876FQ38605099-FDDE64DC-9018-4A51-B1FA-86FC367DB832Q38786854-888D8B1E-7BCA-4EA4-BDF0-562587F805BBQ38807055-78A41CF0-E769-4D62-BB0B-EC1F91DA435FQ42172913-296F5A51-FF32-431C-A58C-1D7177BA0055Q43086271-66289FEF-65F2-421C-A22E-DA80245F1E94Q44545402-0E380D8F-74EE-440C-963C-CAAA94E9BADBQ46051686-12BCFE13-C3CA-4DC7-BABC-F249E002E455Q46297577-578986E9-E6DC-4658-BF5E-46C9B0F8F914Q49680688-6960DF19-4591-4BB5-A61C-38CA6EEBC78CQ50198506-46CDD106-50F9-4883-9698-A1A5A194C19FQ50282637-CBDAA08A-DD84-429C-B418-F16C4A6CAD5B
P2860
The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The synthetic triterpenoid RTA ...... s with chronic kidney disease.
@ast
The synthetic triterpenoid RTA ...... s with chronic kidney disease.
@en
type
label
The synthetic triterpenoid RTA ...... s with chronic kidney disease.
@ast
The synthetic triterpenoid RTA ...... s with chronic kidney disease.
@en
prefLabel
The synthetic triterpenoid RTA ...... s with chronic kidney disease.
@ast
The synthetic triterpenoid RTA ...... s with chronic kidney disease.
@en
P2093
P2860
P1433
P1476
The synthetic triterpenoid RTA ...... s with chronic kidney disease.
@en
P2093
Colin J Meyer
Mahyar Khazaeli
Mohammad A Aminzadeh
Nosratola D Vaziri
Scott A Reisman
P2860
P304
P356
10.3109/00498254.2013.852705
P407
P577
2013-11-06T00:00:00Z